DK0465368T3 - Nye svovlforbindelser afledt af imidazol, fremgangsmåde til deres fremstilling, nye opnåede mellemforbindelser, deres anven - Google Patents

Nye svovlforbindelser afledt af imidazol, fremgangsmåde til deres fremstilling, nye opnåede mellemforbindelser, deres anven

Info

Publication number
DK0465368T3
DK0465368T3 DK91401857T DK91401857T DK0465368T3 DK 0465368 T3 DK0465368 T3 DK 0465368T3 DK 91401857 T DK91401857 T DK 91401857T DK 91401857 T DK91401857 T DK 91401857T DK 0465368 T3 DK0465368 T3 DK 0465368T3
Authority
DK
Denmark
Prior art keywords
imidazole
preparation
aryl
alkyl
amino
Prior art date
Application number
DK91401857T
Other languages
English (en)
Inventor
Jean-Claude Caille
Alain Corbier
Michel Fortin
Gilles Hamon
Simone Jouquey
Jean-Paul Vevert
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9008538A external-priority patent/FR2664271B1/fr
Priority claimed from FR9104882A external-priority patent/FR2675503B1/fr
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0465368T3 publication Critical patent/DK0465368T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Resins (AREA)
DK91401857T 1990-07-05 1991-07-04 Nye svovlforbindelser afledt af imidazol, fremgangsmåde til deres fremstilling, nye opnåede mellemforbindelser, deres anven DK0465368T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9008538A FR2664271B1 (fr) 1990-07-05 1990-07-05 Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
FR9104882A FR2675503B1 (fr) 1991-04-19 1991-04-19 Nouveaux derives soufres de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Publications (1)

Publication Number Publication Date
DK0465368T3 true DK0465368T3 (da) 1999-03-08

Family

ID=26228128

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91401857T DK0465368T3 (da) 1990-07-05 1991-07-04 Nye svovlforbindelser afledt af imidazol, fremgangsmåde til deres fremstilling, nye opnåede mellemforbindelser, deres anven

Country Status (21)

Country Link
US (3) US5412101A (da)
EP (1) EP0465368B1 (da)
JP (2) JP3192171B2 (da)
KR (1) KR100216006B1 (da)
CN (1) CN1045769C (da)
AT (1) ATE166344T1 (da)
AU (1) AU653160B2 (da)
CA (1) CA2046265C (da)
DE (1) DE69129428T2 (da)
DK (1) DK0465368T3 (da)
ES (1) ES2117001T3 (da)
FI (1) FI111542B (da)
HU (1) HU217444B (da)
IE (1) IE912335A1 (da)
IL (1) IL98319A (da)
MA (1) MA22203A1 (da)
MX (1) MX9100092A (da)
OA (1) OA09506A (da)
RU (1) RU2086542C1 (da)
UA (1) UA26130A (da)
WO (1) WO2004074258A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung
GB9213934D0 (en) * 1992-06-30 1992-08-12 Smithkline Beecham Corp Chemical compounds
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
IT1255461B (it) * 1992-07-28 1995-11-02 Luso Farmaco Inst Eteri di imidazoli ad attivita' a ii antagonista
US5376666A (en) * 1992-11-30 1994-12-27 The Du Pont Merck Pharmaceutical Company Angiotension-II receptor blocking, azacycloalkyl or azacycloalkenyl
CZ283315B6 (cs) * 1992-12-17 1998-02-18 Sankyo Company Limited Bifenylové deriváty, způsob výroby a farmaceutické prostředky k léčení hypertense a srdečních onemocnění, které tyto deriváty obsahují
FR2711367B1 (fr) * 1993-10-19 1995-12-01 Roussel Uclaf Nouveau procédé de préparation de dérivés soufrés de l'imidazole et les nouveaux intermédiaires obtenus.
US5395844A (en) * 1993-06-10 1995-03-07 The Du Pont Merck Pharmaceutical Company Imidazole 5-position substituted angiotensin II antagonists
US5409926A (en) * 1993-07-19 1995-04-25 Merck & Co., Inc. AT-2 antagonist inhibition of vascular restenosis
FR2716882B1 (fr) * 1994-03-04 1996-04-05 Roussel Uclaf Utilisation de dérivés de l'imidazole au traitement d'affections impliquant les récepteurs AT1 et AT2 de l'Angiotensine, certains de ces produits, leur préparation, compositions pharmaceutiques.
RU2157368C2 (ru) * 1994-09-26 2000-10-10 Сионоги Энд Ко., Лтд. Производные имидазола и фармацевтическая композиция на их основе
EP0855392A3 (de) 1997-01-22 2000-01-05 Hoechst Aktiengesellschaft Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19739113A1 (de) * 1997-09-06 1999-03-11 Gefinex Polymerschaeume Gmbh Vorexpandierte polyolefinische Schaumpartikel
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
KR20010048940A (ko) * 1999-11-30 2001-06-15 서평원 프로세서의 디바이스 제어 시스템
KR20040022238A (ko) * 2001-08-09 2004-03-11 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
EP1752450A1 (en) 2005-08-01 2007-02-14 Merck Sante Imidazole derivatives as fructose-1,6-bisphosphatase inhibitors and pharmaceutical compositions containing them
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EA020466B1 (ru) 2007-06-04 2014-11-28 Синерджи Фармасьютикалз Инк. Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8236843B2 (en) 2008-09-02 2012-08-07 Elder Pharmaceuticals Ltd. Anti inflammatory compounds
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
JP6807684B2 (ja) * 2016-09-08 2021-01-06 ナブテスコ株式会社 シールアダプタ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179512A (en) * 1977-03-01 1979-12-18 Merck & Co., Inc. 4-Substituted-2-arylimidazoles
PT78388B (en) * 1983-04-12 1986-09-15 Smithkline Beckman Corp Dopamine-beta-hydroxylase inhibitors
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US4882348A (en) * 1987-12-29 1989-11-21 Smithkline Beckman Corporation 2-(aminoalkylthio)imidazoles as dopamine-β-hydroxylase inhibitors
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids

Also Published As

Publication number Publication date
ES2117001T3 (es) 1998-08-01
FI913250A0 (fi) 1991-07-04
OA09506A (fr) 1992-11-15
ATE166344T1 (de) 1998-06-15
IL98319A (en) 1997-04-15
CA2046265C (fr) 2005-10-18
JP3192171B2 (ja) 2001-07-23
CA2046265A1 (fr) 1992-01-06
IE912335A1 (en) 1992-01-15
IL98319A0 (en) 1992-06-21
CN1058775A (zh) 1992-02-19
KR100216006B1 (ko) 1999-08-16
AU653160B2 (en) 1994-09-22
DE69129428T2 (de) 1998-11-05
HU217444B (hu) 2000-01-28
US5599830A (en) 1997-02-04
JPH04230369A (ja) 1992-08-19
US5684028A (en) 1997-11-04
WO2004074258A1 (fr) 2004-09-02
JP2001151759A (ja) 2001-06-05
AU8016391A (en) 1992-01-09
JP3261403B2 (ja) 2002-03-04
UA26130A (uk) 1999-06-07
EP0465368B1 (fr) 1998-05-20
CN1045769C (zh) 1999-10-20
DE69129428D1 (de) 1998-06-25
EP0465368A1 (fr) 1992-01-08
US5412101A (en) 1995-05-02
KR920002552A (ko) 1992-02-28
FI913250A (fi) 1992-01-06
HUT58297A (en) 1992-02-28
FI111542B (fi) 2003-08-15
HU912265D0 (en) 1991-12-30
MA22203A1 (fr) 1992-04-01
RU2086542C1 (ru) 1997-08-10
MX9100092A (es) 1992-02-28

Similar Documents

Publication Publication Date Title
DK0465368T3 (da) Nye svovlforbindelser afledt af imidazol, fremgangsmåde til deres fremstilling, nye opnåede mellemforbindelser, deres anven
NO875188L (no) Karbapenemderivater, fremgangsmaate til fremstilling derav, samt preparater som inneholder dem.
DK75789A (da) Pyrimidinderivater
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
ES8708235A1 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida
ES8306996A1 (es) Procedimiento para preparar derivados de amidas.
DK0498721T3 (da) Nye N-substituerede quinolinforbindelser, fremgangsmåde til deres fremstilling, mellemprodukter deraf, deres anvendelse som
FI943508A (fi) Pyridiinikarboksimidamidiyhdisteet ja niiden käyttö
DK57993D0 (da) Rektalt suppositorie med kontrolleret afgivelse af virksomt stof, fremgangsmaade til fremstilling heraf samt fremgangsmaade til afvaergelse af bivirkninger ved rektal indgivelse af det virksomme stof
ATE46515T1 (de) Phosphonate.
DE3686145D1 (de) Schaedlingsbekaempfungsverbindungen.
ATE49410T1 (de) 1-aryl-5-alkoximinoalkylamino-pyrazole.
DK169989A (da) Heterocyclisk substituerede alkyl- og alkenylsulfonylurinstoffer, fremgangsmaader til deres fremstilling samt deres anvendelse som herbicider og plantevaekstregulerende midler
DK0648763T3 (da) Ny fremgangsmåde til fremstilling af afledede svovlforbindelser af imidazol og de opnåede nye mellemstoffer
ATE82971T1 (de) Substituierte imidazolone mit herbizider wirkung.
ES8700224A1 (es) Procedimiento para la preparacion de un nuevo derivado de lafenil-3-propeno-2 amina
AU2175083A (en) 2-(substituted amino)-pyrimid-4-one derivatives
HUP0003632A2 (hu) Eljárás szubsztituált 2-nitro-guanidin-származékok és intermedierjeik előállítására
ES8604941A1 (es) Procedimiento para la obtencion de benzodisultamas
DK255185A (da) Substituerede tetrahydrothiopyran-2,4-dioner, deres fremstilling og anvendelse som herbicider
HUT77767A (hu) Imidazolszármazékok új alkalmazása, imidazolszármazékok, eljárás előállításukra és a kapott új köztitermékek, gyógyszerkénti alkalmazásuk, és az ezeket tartalmazó gyógyászati készítmények
DK628486D0 (da) Pyranderivater, fremgangsmaade til fremstilling heraf samt deres anvendelse
PT77541B (en) Process for preparing substituted 9h-8-oxo-pyrimido<2,1-f>puri-ne-2,4-diones and pharmaceutical compositions containing them
TH3367A (th) สารผสมกำจัดศัตรูที่มีสารประเภทฟอสฟอรัสเฮทเทอโรไซคลิคผสมอยู่ด้วย
PT64732A (en) Process for the preparation of new thiadiazolylimidazolines